Marskem Biologicals Private Limited
About Marskem Biologicals Private Limited
Data last updated:
Marskem Biologicals Private Limited is a private limited company based in Vijayawada, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24290AP2019PTC113626.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Satyanarayana Annam and Lakshmi Annam.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 26 – 12 – 13 Boddapati Vari Street Gandhinagar, Vijayawada, Andhra Pradesh, India – 520003.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.86 Lakh. For the same year it recorded a net profit of ₹73,000 (net margin 25.6%) and EBITDA of ₹98,700 (EBITDA margin 34.5%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years.
Company details
Contact details
Marskem Biologicals Private Limited's registered office is in Vijayawada, Andhra Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address26 – 12 – 13 Boddapati Vari Street Gandhinagar, Vijayawada, Andhra Pradesh, India – 520003
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Marskem Biologicals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Marskem Biologicals Private Limited
FY 2024 filings availableMarskem Biologicals Private Limited reported revenue of ₹2.86 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over three years. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹98,700 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹73,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 34.5% | ||||
| Net Profit Margin | 25.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Marskem Biologicals Private Limited, buy the company report.
Board of directors of Marskem Biologicals Private Limited
Marskem Biologicals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyanarayana Annam | Director | 13 Dec 2019 | 6 Years 10 Months | Current |
| Lakshmi Annam | Director | 13 Dec 2019 | 6 Years 10 Months | Current |
| Annam Ramakrishna Rao | Director | 13 Dec 2019 | 6 Years 10 Months | Current |
Peer comparison
Marskem Biologicals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| DPD Drugs & Pharmaceuticals Private Limited | ₹2.95 Lakh (FY 2017) | -35.0% | New Delhi, Delhi, India | |||
| Systochem Formulations Private Limited | ₹2.95 Lakh (FY 2025) | 10.0% | Delhi, India | |||
| Hendrix Pharmaceuticals Private Limited | ₹2.93 Lakh (FY 2025) | Hyderabad, Telangana, India | ||||
| BGR Pharmaceuticals Private Limited | ₹2.91 Lakh (FY 2022) | Lucknow, Uttar Pradesh, India | ||||
| Sri Dhanwantari Probiotics Private Limited | ₹2.87 Lakh (FY 2025) | -18.0% | Sathyamangalam, Tamil Nadu, India | |||
| Marskem Biologicals Private Limitedthis company | ₹2.86 Lakh (FY 2025) | ₹73,000 | 25.6% | Vijayawada, Andhra Pradesh, India | ||
| Kreative (Export and Import) Pvt Ltd | ₹2.85 Lakh (FY 2016) | 33.0% | Mumbai, Maharashtra, India | |||
| Progiene Formulations Private Limited | ₹2.83 Lakh (FY 2022) | Pune, Maharashtra, India | ||||
| Shree Medico Private Limited | ₹2.82 Lakh (FY 2023) | -8.0% | Kolkata, West Bengal, India | |||
| Max Nutra Medico Private Limited | ₹2.82 Lakh (FY 2022) | 31.0% | Pune, Maharashtra, India | |||
| Andinil Pharmaceuticals Private Limited | ₹2.81 Lakh (FY 2025) | -45.0% | Burdwan, West Bengal, India |
To see the full peer comparison of Marskem Biologicals Private Limited, buy the company report.
Auditor
Marskem Biologicals Private Limited is audited by Gaddam Satyanarayana and Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gaddam Satyanarayana and Co | FY 2023 | 000836S |
Shareholding
The shareholding of Marskem Biologicals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Marskem Biologicals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Marskem Biologicals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Marskem Biologicals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Marskem Biologicals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Marskem Biologicals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Annam Ramakrishna Rao was appointed as Director on 13 Dec 2019.
Frequently asked questions
Marskem Biologicals is an active private limited company based in Vijayawada, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 December 2019 (7+ years old) and is registered under CIN U24290AP2019PTC113626.
Marskem Biologicals has 3 current directors:
- Satyanarayana Annam - Director
- Lakshmi Annam - Director
- Annam Ramakrishna Rao - Director
The latest financial statements of Marskem Biologicals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Marskem Biologicals is U24290AP2019PTC113626. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marskem Biologicals was incorporated on 13 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Marskem Biologicals by revenue are DPD Drugs & Pharmaceuticals Private Limited, Systochem Formulations Private Limited, Hendrix Pharmaceuticals Private Limited, BGR Pharmaceuticals Private Limited, Sri Dhanwantari Probiotics Private Limited and 5 more, all in the Pharma industry (Formulations).
Annam Ramakrishna Rao was appointed as Director on 13 Dec 2019. Lakshmi Annam was appointed as Director on 13 Dec 2019. Satyanarayana Annam was appointed as Director on 13 Dec 2019.
The registered office of Marskem Biologicals is at 26 – 12 – 13 Boddapati Vari Street Gandhinagar, Vijayawada, Andhra Pradesh, India – 520003.
Marskem Biologicals operates in the pharma industry, in the drug formulation and development segment.
Marskem Biologicals can be reached at its registered office: 26 – 12 – 13 Boddapati Vari Street Gandhinagar, Vijayawada, Andhra Pradesh, India – 520003.
Marskem Biologicals is registered under the jurisdiction of the Registrar of Companies (ROC), Vijayawada.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
